Navigation Links
uBiome Announces SmartBiome ID™: Sample-Agnostic Pathogen Detection Platform
Date:2/10/2017

Microbial genomics leader uBiome announces SmartBiome ID™ -- the first application on its SmartBiome™ platform, announced in 2016. Using uBiome’s precision sequencing™ technology, SmartBiome ID allows hypothesis-free detection of hundreds of bacterial, viral, fungal, and eukaryotic targets from a single sample of a variety of types, including blood, stool, and urine, among others.

uBiome’s clinical laboratory received accreditation from the College of American Pathologists (CAP) in 2016 after a rigorous process of inspection and qualification. uBiome’s clinical laboratory is also certified by the Centers for Medicare and Medicaid Services (CMS) under CLIA. Only the top 2.75 percent of laboratories are CAP-accredited.

Dr. Jessica Richman, CEO and co-founder of uBiome, says: “uBiome has been involved in this work for several years, including our continuing project with the Centers for Disease Control and Prevention, publicly announced in December 2015, and other studies on related topics such as sepsis since 2014. SmartBiome ID is another step in this evolution, enabling broader understanding of pathogens in a variety of sample types in the clinical setting.”

Hospitals, physicians, and other partners interested in partnering with uBiome to pilot SmartBiome ID in their clinics and institutions can sign up for more information here: ubome.com/go/smartbiomeidform

Dr. Zachary Apte, CTO and co-founder of uBiome, and Adjunct Professor of Biochemistry and Biophysics at the University of California, San Francisco adds: “One of the most exciting aspects of this assay is that our microbial genomics techniques allow us to interrogate both cell-free DNA and lysates. I’m excited about the inventions our team has created over the past several years that have enabled the development of SmartBiome ID and the tools it allows us to offer in terms of pathogen detection.”

Interested physician and hospital partners can sign up for more information here: https://ubiome.com/go/smartbiomeidform

Founded in 2012, uBiome is the world’s leading microbial genomics company. uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC, and other leading investors. uBiome’s mission is to explore important research questions about the microbiome and to develop reliable, accurate products and services focused on the microbiome.

Contact:
Julie Taylor
julie(at)ubiome(dot)com
Ph: +1 (415) 212-9214

Read the full story at http://www.prweb.com/releases/2017/02/prweb14063417.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Boston Children’s Hospital and uBiome to Investigate Premature Births
2. Stanford Medicine and uBiome Investigate Relationship Between Gut Bacteria and Diabetes
3. Dutch Journal of Medical Microbiology Publishes uBiome Science Editor’s Most Recent Microbiome Paper
4. Self-Experimenting Scientist Receives uBiome Grant to Investigate Consequences of Long-Term Antibiotic Use for Skin Conditions
5. uBiome Appoints Boston Children’s Hospital Genomics Expert, Dr. Olaf Bodamer, to its Advisory Board
6. UCSF Researcher to Investigate Diabetes and the Microbiome in Filipino Populations with uBiome Microbiome Impact Grant
7. uBiome Joins Google, SpaceX, and Oculus as 2016 World Technology Award Finalist
8. uBiome Announces SmartBiomeTM, a Novel Comprehensive Metagenomic Deep Sequencing Research Platform
9. uBiome Awards Microbiome Impact Grant to Explore Effects of Heavy Drinking and Smoking on Oral Microbiome
10. Huffington’s Thrive Global Pop-Up Store Showcases uBiome Gut Explorer Kits for the Microbiome
11. Stanford Microbiome Pioneer Elisabeth Bik Becomes New Science Editor at uBiome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... 2019 , ... Tucker, a Labrador retriever, was just a puppy when he ... and lame on his right hip and elbow. At one year of age, Tucker ... case the vet had seen.” He was prescribed pain medications, both oral and injectable, ...
(Date:9/17/2019)... ... September 16, 2019 , ... When a lot of researchers think of Visikol, ... complete 3D characterization of tissues through the use of confocal and light sheet microscopy. ... and advanced cell culture focused contract research organization and today offers 3D tissue ...
(Date:9/11/2019)... PRUSSIA, Pa. (PRWEB) , ... September 09, 2019 ... ... problems for life sciences companies and government agencies, announced that its president and ... invitation-only group of successful business leaders. , The Forbes Council accepted Gallivan based ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... held at the Bausparkasse Schwäbisch Hall AG, Schwabisch Hall, Germany, on Sept. 18-19, ...
Breaking Biology Technology:
(Date:8/19/2019)... ... August 19, 2019 , ... Since ... use of ultra-thin two dimensional slices which are placed on microscope slides, stained ... complex tissues and complicated features such as vasculature and thus researchers in the ...
(Date:8/14/2019)... JUPITER, Fla. (PRWEB) , ... August 14, 2019 ... ... scheduled to broadcast 4Q/2019, will explore how developments in microbiome therapeutics are helping ... your local listings for more information. , Advancements will educate about the DECODE.DESIGN.CURE™ ...
(Date:8/14/2019)... ... ... Gateway Genomics , a leading developer of direct-to-consumer genetic tests that ... Inc. 500|5000 list of fastest growing private companies, in the first year the ... generating revenue by March 31, 2015. Ranking in the list is determined by the ...
Breaking Biology News(10 mins):